2018年

Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y.
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
N Engl J Med, 378(6):529-538, 2018.

Fujii R, Komatsu R, Sato T, Seki I, Konomi K, Aono H, Niki H, Yudoh K, Nishioka K, Nakajima T.
SPACIA1/SAAL1 Deletion Results in a Moderate Delay in Collagen-Induced Arthritis Activity, along with mRNA Decay of Cyclin-dependent Kinase 6 Gene.
Int J Mol Sci, 19(12). pii: E3828, 2018.

Abdallah N, Nagasaka M, Abdulfatah E, Shi D, Wozniak AJ, Sukari A.
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation.
Lung Cancer: Targets and Therapy, 9:85-90, 2018.

Ou SI, Nagasaka M, Zhu VW.
Liquid Biopsy to Identify Actionable Genomic Alterations.
Am Soc Clin Oncol Educ Book, (38):978-997, 2018.

Shimizu, J, Yamano Y, Kawahata K, Suzuki N.
Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics.
Medicine, 97:42(e12837), 2018.

Oka T, Mizuno H, Sakata M, Fujita H, Yoshino T, Yamano Y, Utsumi K, Masujima T, Utsunomiya A.
Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy.
Scientific Reports, 8:14979, 2018.

Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, Umeki K, Kubota R, Sasada K, Sobata R, Matsumoto C, Kaneko N, Tezuka K, Matsuoka S, Utsunomiya A, Koh KR, Ogata M, Ishitsuka K, Taki M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Watanabe T, Hamaguchi I.
Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.
Microbiol Immunol, 62:673-676, 2018.

Sato T, Yamano Y.
Targeting human T-lymphotropic virus type 1-infected cells with an anti-C-C chemokine receptor 4 antibody in T-lymphotropic virus type 1-associated myelopathy.
Clinical and Experimental Neuroimmunology, 9(3):153-154, 2018.

Kawano N, Yoshida S, Kawano S, Kuriyama T, Tahara Y, Toyofuku A, Manabe T, Doi A, Terasaka S, Yamashita K, Ueda Y, Ochiai H, Marutsuka K, Yamano Y, Shimoda K, Kikuchi I.
The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
J Clin Exp Hematop, 107-121, 2018.

Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, Tsuboi Y, Takata A, Yamano Y.
Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity.
Front Microbiol, 9:1651, 2018.

Hirano M, Jimbo K, Ogawa M, Ochi K, Makiyama J, Kawamata T, Yokoyama K, Tanaka T, Inamoto Y, Yamano Y, Fukuda T, Uchimaru K, Imai Y, Tojo A.
Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation Bone Marrow Transplantation.
Bone Marrow Transplantation, Published online 23 July 2018.
DOI: https://doi.org/10.1038/s41409-018-0202-9

Sukari A, Nagasaka M, Abdallah N.
Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors.
Oral Oncol, 80:100-102, 2018.

Nagasaka M, Gadgeel SM.
Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.
Expert Rev Anticancer Ther, 18(1):63-70, 2018.

Shimizu J, Yamano Y, Yudoh K, Suzuki N.
Organ Involvement Pattern Suggests Subgroups within Relapsing Polychondritis.
Arthritis Rheumatol, 70(1):148-149, 2018.

Abdallah N, Nagasaka M, Abdulfatah E, Shi D, Wozniak AJ, Sukari A.
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation.
Lung Cancer (Auckl), 9:85-90, 2018.

Ou SI, Nagasaka M, Zhu VW.
Liquid Biopsy to Identify Actionable Genomic Alterations.
Am Soc Clin Oncol Educ Book, 38:978-997, 2018.

Nagasaka M, Abdallah N, Samantray J, Sukari A.
Is this really just “fatigue”? A case series of immune-related central adrenal insufficiency secondary to immune checkpoint inhibitors.
Clin Case Rep, 6:1278-1281, 2018.

山野嘉久.
HTLV-1関連脊髄症.
感染症, 48(6):25-28,2018.

山野嘉久.
「特集　HTLV-1関連脊髄症―病態解明と治療の最新情報」はじめに
医学のあゆみ, 267(10):735, 2018.

八木下尚子.
HAMの臨床情報基盤―患者レジストリ“HAMねっと”.
医学のあゆみ, 267(10):746-750, 2018.

佐藤知雄.
HAMの疾患活動性分類と治療.
医学のあゆみ, 267(10):756-760, 2018.

山内淳司.
腎移植によるHAM発症のリスク.
医学のあゆみ, 267(10):767-770, 2018.

山野嘉久、山内淳司、新谷奈津美、八木下尚子、佐藤知雄.
HTLV-1関連脊髄症（HAM）の病態・診断・治療.
神経内科, 89(3):297-303, 2018.

森尾裕志、大森圭貢、井澤和大、堅田紘頌、石山大介、小山真吾、中尾陽光、山野嘉久.
高齢入院患者におけるペットボトルの開栓に必要な握力.
専門リハビリ, 17:30-35, 2018.

八木下尚子、山野嘉久.
希少難病HAMの患者レジストリを活用した治療薬開発への取り組みと展望
Jpn Pharmacol Ther (薬理と治療), 46(7):1113-1116, 2018.